Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2 variants that shape baseline appetite-regulation and energy-balance biology

Tirzepatide may be the better choice if: Maximum weight loss is the priority clinical data consistently shows superior outcomes at every benchmark You have a higher starting BMI (35+) the absolute weight loss advantage is most meaningful at higher baseline weights You have insulin resistance, prediabetes, or metabolic syndrome tirzepatides dual GIP/GLP-1 mechanism offers stronger glycemic and metabolic improvements than semaglutide alone, making it particularly effective tirzepatide for insulin resistance cases You plateaued or under-responded to semaglutide tirzepatide frequently produces results where semaglutide stalled Insurance covers Zepbound or Mounjaro when covered, the cost gap narrows significantly Learn more about our tirzepatide weight loss program and whether you qualify
The answer depends on the individual patient
CNS Drugs 28 , 875886 (2014)
An updated meta-analysis of nine randomised controlled trials (RCTs), including 8,920 patients with HF and T2D, reported a 13% reduction in major adverse cardiovascular events in the GLP-1 RA compared with placebo arm